Bantam Pharmaceutical, LLC

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Bantam Pharmaceutical, LLC - overview

Established

2015

Location

New York, NY, US

Primary Industry

Pharmaceuticals

About

Founded in 2015 and based in New York, US, Bantam Pharmaceutical, LLC is a biopharmaceutical company that provides a therapeutical solution for oncology treatment. The company's president and CEO are Mr. Michael Stocum who also holds corporate roles in pharmaceuticals with GlaxoWellcome/GSK, biologics at Organon (now Merck), and molecular diagnostics at Organon Teknika (now bioMerieux). In September 2021, Bantam Pharmaceutical, LLC raised its latest USD 25 million Seed funding from various unspecified investors.


The company offers BTM-3566, a selective regulator of mitochondrial dynamics that targets a pathway involved in mitochondrial homeostasis that promotes cancer cell death in a variety of tumor types using a protein translational phenotypic screen to find a clinical candidate and related chemicals to give oncology treatment. The company plans to submit its Investigational New Drug application in February 2022 and start Phase 1 clinical studies in patients with B-cell hematological malignancies in the second quarter of 2022.


Primary Industry

Pharmaceuticals

Sub Industries

Biopharmaceuticals, Oncology/Cancer Treatment, Pharmaceutical Research & Development

Website

www.bantampharma.com

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.